Biotech startups that raised a seed round in Cambridge, Massachusetts
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| STRM.BIO | Cambridge | Seed | $8.0M | 2026-01-07 |
| NeuroBionics | Cambridge | Seed | $4.2M | 2025-12-10 |
| Kano Therapeutics | Cambridge | Seed | $5.0M | 2025-11-07 |
| Elemind Technologies | Cambridge | Seed | $12.0M | 2024-02-06 |
| Via Scientific | Cambridge | Seed | $5.0M | 2024-01-09 |
| Symbionics | Cambridge | Angel | $4.1M | 2023-10-24 |
| Nvelop Therapeutics | Cambridge | Seed | $100.0M | 2023-09-20 |
| Innovac Therapeutics | Cambridge | Seed | $18.0M | 2023-09-01 |
8 rows of the CSV in 5 of its 18 columns.
- The 66 biotech startups in Cambridge, Massachusetts whose last round is a seed round have raised $435.3M in total.
- 9 of them closed their most recent round in the last 12 months, $51.9M combined.
- The largest of those rounds is TRIMTECH Therapeutics' $14.0M seed round, dated June 2026.
- The most recent is Ambitious Bio's $6.0M seed round on 22 September 2026.
- Taihill Venture is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 54 companies (82%).
- 48% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 1 to 10 employees (58% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 66| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| STRM.BIO | STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy. | Biotech | Seed | $8.0M | 2026-01-07 | $10.1M | Bill & Melinda Gates Foundation, NYBC Ventures, NCATS | 11 to 50 | 2019 |
| NeuroBionics | NeuroBionics develops bioelectronic medicine devices that treat disease by modulating nerve activity. | Biotech | Seed | $4.2M | 2025-12-10 | $9.2M | MedTech Innovator, Dolby Family Ventures, GreyMatter +1 | 1 to 10 | 2023 |
| Kano Therapeutics | Kano Therapeutics develops single-stranded DNA for targeted gene correction. | Biotech | Seed | $5.0M | 2025-11-07 | $7.1M | Metaplanet, Taihill Venture, Vsquared Ventures +2 | 1 to 10 | 2021 |
| Elemind Technologies | Elemind Technologies develops neuromodulation techniques that shape brainwaves and change brain states. | Biotech | Seed | $12.0M | 2024-02-06 | $12.0M | Village Global, E14 Fund, Evolution VC Partners +2 | 11 to 50 | 2019 |
| Nvelop Therapeutics | Nvelop Therapeutics develops genetic medicines for patients with severe genetic diseases. | Biotech | Seed | $100.0M | 2023-09-20 | $100.0M | F-Prime, Atlas Venture, 5AM Ventures +1 | 51 to 100 | 2022 |
Table 1. Biotech startups that raised a seed round in Cambridge, Massachusetts: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 66.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | STRM.BIO | STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy. | Biotech | Seed | $8.0M | 2026-01-07 | $10.1M | Bill & Melinda Gates Foundation, NYBC Ventures, NCATS | 11 to 50 | 2019 |
| 2 | NeuroBionics | NeuroBionics develops bioelectronic medicine devices that treat disease by modulating nerve activity. | Biotech | Seed | $4.2M | 2025-12-10 | $9.2M | MedTech Innovator, Dolby Family Ventures, GreyMatter +1 | 1 to 10 | 2023 |
Table 2. Biotech startups that raised a seed round in Cambridge, Massachusetts: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Taihill Venture | Venture capital firm | Boston, United States | 2 | 3% | ||
| 2 | Half Court Ventures | Venture capital firm | Boston, United States | 2 | 3% | ||
| 3 | NCATS | Government investment office | Bethesda, United States | 1 | 2% | 1 | STRM.BIO |
| 4 | NYBC Ventures | Venture capital firm | Boston, United States | 1 | 2% | 1 | STRM.BIO |
| 5 | Bill & Melinda Gates Foundation | Family office | Seattle, United States | 1 | 2% | 1 | STRM.BIO |
| 6 | MedTech Innovator | Startup accelerator | Los Angeles, United States | 1 | 2% | 1 | NeuroBionics |
| 7 | Future Ventures | Venture capital firm | Calgary, Canada | 1 | 2% | 1 | NeuroBionics |
| 8 | GreyMatter | Venture capital firm | New York, United States | 1 | 2% | 1 | NeuroBionics |
| 9 | Dolby Family Ventures | Venture capital firm | San Francisco, United States | 1 | 2% | 1 | NeuroBionics |
| 10 | Metaplanet | Venture capital firm | Tallinn, Estonia | 1 | 2% | ||
| 11 | Vsquared Ventures | Venture capital firm | Munich, Germany | 1 | 2% | ||
| 12 | Engine Ventures | Venture capital firm | Cambridge, United States | 1 | 2% | ||
| 13 | Amino Collective | Venture capital firm | Berlin, Germany | 1 | 2% | ||
| 14 | Village Global | Micro VC fund | Covina, United States | 1 | 2% | ||
| 15 | LDV Partners | Venture capital firm | Palo Alto, United States | 1 | 2% |
Table 3. Biotech startups that raised a seed round in Cambridge, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 54 | 82% | $378.8M |
| Software | 12 | 18% | $72.0M |
| Artificial intelligence | 10 | 15% | $56.9M |
| Hardware | 2 | 3% | $16.1M |
| Fintech | 1 | 2% | $155K |
Table 4. Biotech startups that raised a seed round in Cambridge, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 66 | 100% | $2.6M |
Table 5. Biotech startups that raised a seed round in Cambridge, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 11% | $6.0M |
| August 2026 | 2 | 22% | $8.7M |
| June 2026 | 2 | 22% | $24.0M |
| March 2026 | 1 | 11% | $1.0M |
| January 2026 | 2 | 22% | $8.0M |
| December 2025 | 1 | 11% | $4.2M |
Table 6. Biotech startups that raised a seed round in Cambridge, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 8 | 12% | $47.7M |
| 2025 | 11 | 17% | $49.2M |
| 2024 | 6 | 9% | $37.0M |
| 2023 | 5 | 8% | $122.1M |
| 2022 | 7 | 11% | $35.5M |
| 2021 | 6 | 9% | $33.8M |
Table 7. Biotech startups that raised a seed round in Cambridge, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 12 | 19% |
| 2020 to 2022 | 19 | 30% |
| 2015 to 2019 | 22 | 34% |
| 2010 to 2014 | 7 | 11% |
| Before 2010 | 4 | 6% |
Table 8. Biotech startups that raised a seed round in Cambridge, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 38 | 58% |
| 11 to 50 | 23 | 35% |
| 51 to 100 | 1 | 2% |
| 101 to 250 | 1 | 2% |
| 501 to 1,000 | 1 | 2% |
| 1,001 to 5,000 | 1 | 2% |
Table 9. Biotech startups that raised a seed round in Cambridge, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is a seed round and its headquarters is in Cambridge, Massachusetts. On 16 November 2026 that is 66 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 66 rows: 15 have no round amount, 0 no city and 14 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Cambridge, Massachusetts whose last round is a seed round are on the list?
- 66, in the file dated 16 November 2026. 9 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 66 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.